clinical and serological features of triple autoantibody negative patients with systemic sclerosis insights from the multicentric spring registry of the italian society for rheumatology

Original title: “Clinical and serological features of triple autoantibody-negative patients with systemic sclerosis: insights from the multicentric SPRING registry of the Italian Society for Rheumatology.”

scoping literature review on applied definitions of very early diagnosis of systemic sclerosis vedoss and pre systemic sclerosis in original articles

Original title: “Scoping literature review on applied definitions of very early diagnosis of systemic sclerosis (VEDOSS) and pre-systemic sclerosis in original articles.”

factors associated with variations in the 6 minute walk distance during the follow up of patients with systemic sclerosis

Original title: “Factors associated with variations in the 6-minute walk distance during the follow-up of patients with systemic sclerosis.”

environmental and occupational factors in the aetiopathogenesis of systemic sclerosis insights from a large multinational patient survey

Original title: “Environmental and occupational factors in the aetiopathogenesis of systemic sclerosis: insights from a large multinational patient survey.”

retrospective analysis of clinical characteristics of systemic sclerosis associated interstitial lung disease

Original title: “A retrospective analysis of clinical characteristics of systemic sclerosis-associated interstitial lung disease.”

combination therapy with mycophenolate mofetil nintedanib and tocilizumab in a patient with progressive systemic sclerosis associated interstitial lung disease a case report and a literature review

Original title: “Combination therapy with mycophenolate mofetil, nintedanib, and tocilizumab in a patient with progressive systemic sclerosis-associated interstitial lung disease : A case report and a literature review.”

Company targets new approach to treating rheumatoid arthritis and systemic sclerosis

Original title: “Quell launches chill phase 1/2 trial for novel cartreg therapy”

biologic rescue with tocilizumab a case of refractory chronic pericardial effusion in systemic sclerosis

Original title: “Biologic Rescue With Tocilizumab: A Case of Refractory Chronic Pericardial Effusion in Systemic Sclerosis.”

longitudinal assessment of the juvenile systemic sclerosis severity score application in the national registry for childhood onset scleroderma

Original title: “Longitudinal Assessment of the Juvenile Systemic Sclerosis Severity Score: Application in the National Registry for Childhood Onset Scleroderma.”

multifaceted role of platelets in systemic sclerosis beyond haemostasis

Original title: “The multifaceted role of platelets in systemic sclerosis: beyond haemostasis!”

drug development in systemic sclerosis novel therapeutics to watch

Original title: “Drug development in systemic sclerosis: novel therapeutics to watch.”

cytometry based blood immune cell markers associated with clinical outcomes in systemic sclerosis protocol for a systematic review

Original title: “Cytometry-based blood immune cell markers associated with clinical outcomes in systemic sclerosis: protocol for a systematic review.”

management of pulmonary arterial hypertension in systemic sclerosis from classical treatments to new horizons

Original title: “Management of pulmonary arterial hypertension in systemic sclerosis: from classical treatments to new horizons.”

advancing drug development for systemic sclerosis by prioritising findings from human genetic association studies

Original title: “Advancing drug development for systemic sclerosis by prioritising findings from human genetic association studies.”

Raising awareness and celebrating the lives of children with Schaaf-Yang Syndrome on Rare Disease Day. Celebrate Rare with us with our Rare Disease Day Toolkit. Discover simple ways to: ✅ Raise awareness ✅ Share your story ✅ Make an impact · Together, we inspire hope, amplify voices, and work toward a future where every individual—regardless of diagnosis—is recognized for the extraordinary qualities that make them uniquely beautiful. ... Nicci has been dedicated to community-building and advocacy work for years, even before the birth of her son, Will, in 2020. With February 28 marking Rare Disease Day, we honor the courage, joy, and resilience of families living with Schaaf-Yang Syndrome (SYS). The Foundation for Prader-Willi Research (federal tax id 31-1763110) is a nonprofit corporation with federal tax exempt status as a public charity under section 501(c)(3). Foundation for Prader-Willi Research Phone: 888-322-5487 Email: [email protected]

Original title: “Celebrating Rare Disease Day: Spotlight on Two Inspiring Families”

engaging the pd 1 pathway in systemic sclerosis attenuates inflammation driven fibrosis

Original title: “Engaging the PD-1 pathway in systemic sclerosis attenuates inflammation-driven fibrosis.”

impact of hydroxychloroquine on mortality and cardiovascular outcomes in systemic sclerosis a retrospective cohort study

Original title: “Impact of Hydroxychloroquine on Mortality and Cardiovascular Outcomes in Systemic Sclerosis: A Retrospective Cohort Study.”